Healthcare -
Biotechnology - NASDAQ - US
$ 1.27
1.6 %
$ 145 M
Market Cap
-0.77
P/E
FATE - OPERATING INCOME
Operating Income FATE - Fate Therapeutics, Inc.
-191 M
LAST VALUE
6.30%
2 YEAR CAGR
-23.21%
5 YEAR CAGR
-26.84%
10 YEAR CAGR